Prusky Lab
News & Impact

You are here

Reduction of Visual Impairment with Elamipretide in Rodent Models of Diabetes, Aging, and Retinitis Pigmentosa

PRESENTATION: 
Invited Talk
May 2019
Venue: 
Stealth Biotherapeutics, Inc, Boston, MA

We have had success in reducing visual impairment in rodent models of aging and retinal disease, by targeting and improving mitochondrial function with a drug called Elamipretide. The results have already stimulated successful human clinical trials for visual indications, and the approach holds promise to extend the visual healthspan as we age. 

Associated

Research Methods